# Long-Term Clinical Benefit in EGFR-Mutant Lung Adenocarcinoma With Local Squamous Cell Carcinoma Transformation After EGFR TKI Resistance: A Case Report

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/long-term-clinical-benefit-in-egfr-mutant-lung-adenocarcinoma-with-local/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Junru Ye,Yutong Ma,Qiuxiang Ou,Junrong Yan,Bin Ye,Yuping Li |
| Citations | 7 |
| DOI | 10.3389/fonc.2022.883367 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fonc.2022.883367/pdf |
| OpenAlex ID | https://openalex.org/W4281556534 |
| PMID | 35692748 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Junru Ye](https://scholariq.org/researchers/junru-ye/)

## Paper journal

- [Frontiers in Oncology](https://scholariq.org/journals/frontiers-in-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.